Literature DB >> 15497473

Effect of prolonged physical exercise on urinary proANP1-30 and proANP31-67.

Enrico Cappellin1, Elio F De Palo, Rosalba Gatti, Giuseppe Soldà, Wolfgang Woloszczuk, Paolo Spinella.   

Abstract

Dynamic exercise strongly affects atrial natriuretic peptides (ANP), in particular the mature bioactive alphaANP and the proANP fragments, namely proANP1-98, proANP1-30 and proANP31-67. The proANPs influence kidney functions and their plasma levels increase after physical exercise. We measured urinary proANP1-30 and proANP31-67 levels before and at the end of physical exercise in 28 well-trained male cyclists. For the first time, the proANP1-30 and proANP31-67 urinary levels in athletes before and at the end of a prolonged agonistic bicycle race were measured. Urinary creatinine and total proteins were also measured. The urinary proANP31-67, creatinine and total protein levels were significantly higher at the end of exercise than before. In contrast, proANP1-30/protein and proANP31-67/protein ratios decreased after exercise. Even proANP1-30/creatinine and proANP31-67/creatinine ratios were lower after exercise. A significant correlation between proANP1-30 and proANP31-67 urinary levels at the end of exercise was found. The proANP31-67/creatinine ratio before and after exercise also showed a significant correlation. The variation of urinary proANP fragments confirmed their possible role in physical exercise. In particular, it could be interpreted as a response of the body or kidney to renal impairment occurring during exercise.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15497473     DOI: 10.1515/CCLM.2004.212

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

1.  Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exercise.

Authors:  Júlio C de Almeida; Clodoaldo L Alves; Luiz Carlos de Abreu; Monica A Sato; Fernando L Fonseca; Carlos B de Mello Monteiro; Luiz Carlos M Vanderlei; Hugo Macedo; Carlos M Tavares; Dafne Herrero; Luciano Mr Rodrigues; Vitor E Valenti
Journal:  Int Arch Med       Date:  2012-02-07

Review 2.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.